French Court of Appeal overturns French Competition Authority decision on disparagement in the pharma sector
The Court of Appeal quashed the French Competition Authority's decision fining Novartis, Roche and Genentech EUR 444 million for abusing their collective dominant position, providing welcome clarity on the legal test to assess communications by pharmaceutical companies to the public and to health authorities.
Clifford Chance
